UPL LTD

UPL LTD has been granted 92 US utility patents between 2015 and 2025, placing UPL LTD at rank #3,947 across all assignees tracked by PlainPatent. This portfolio spans 32 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.1 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a Foreign Corporation, UPL LTD is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 52.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 70 grants, compared with 22 in the 2015–2019 window — a +218% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. UPL LTD's 9.1 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 32 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark UPL LTD against peers pursuing similar technology classes.